טוען...
Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
SIMPLE SUMMARY: Primary central nervous system lymphoma is a rare disease with limited therapeutic options. A more profound understanding of the molecular mechanisms that underlie this disease has fostered the development of novel therapeutic approaches. Key developments for the treatment of primary...
שמור ב:
| הוצא לאור ב: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8234854/ https://ncbi.nlm.nih.gov/pubmed/34203062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123073 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|